Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Impact of CADx on Endoscopists' Histologic Characterization of Diminutive Colorectal Polyps

NCT: NCT07389759 · COMPLETED

NCT IDNCT07389759
StatusCOMPLETED
Start Date2026-01-03
Completion2026-03-31
SponsorShanghai Jiao Tong University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

This study evaluates the impact of CADx assistance on endoscopists' histologic characterization of diminutive colorectal polyps (≤5 mm) during colonoscopy. The primary objective is to determine whether CADx assistance increases the proportion of endoscopists who meet PIVI-related performance thresholds, thereby supporting implementation of the "resect and discard" and "diagnose and leave" strategies in routine clinical practice.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑